Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Recruiting · NCT05922124 · Registry updated 2025-08-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii | Acinetobacter Bacteremia; Acinetobacter Pneumonia; Carbapenem Resistant Bacterial Infection | Recruiting | Phase 4 | 2025-08-01 | NCT05922124 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rambam Health Care Campus | Haifa | Israel | 17 |
| Shamir Medical Center (Assaf Harofeh) | Tel Aviv | Israel | 1 |
| Sheba Tel HaShomer Medical Campus | Ramat Gan | Israel | 1 |